Search

everythinglearnresearchcommunity

for

Search:↓

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Different rheumatological diseases can cause specific skin problems.

Inflammation in psoriasis may trigger antimicrobial peptides and cell death.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

A woman with long-term scalp psoriasis developed rare scarring hair loss that didn't fully respond to treatments.

Patients with Frontal fibrosing alopecia in Morocco often have skin conditions and thyroid disorders.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

New gene mutations linked to skin conditions were found, bacteria and chemicals may worsen acne, a dog mutation could exist in humans, virus-like elements might be involved in psoriasis, and a vitamin D3 treatment doesn't prevent chemotherapy-related hair loss.

Nails can reveal important health information about skin and body conditions.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Psoriasis treatment may affect body hair growth, with a complex relationship between skin and hair growth mechanisms.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

The document discusses various skin disorders and new therapeutic approaches.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.

Nanospanlastics are effective in targeted drug delivery for chronic diseases, improving skin conditions, treating hair loss, and increasing drug absorption.

Some moles can disappear naturally, maintenance therapy for Stage 1 mycosis fungoides may not be necessary, allergic skin reactions in children are rising, weekly methotrexate for psoriasis is more effective than daily, long-term finasteride use improves hair growth with few side effects, and petrolatum improves UV therapy for psoriasis.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Psoriasis patients have immune cells that respond more strongly to signals and stimuli due to an intrinsic cellular defect.

Sebaceous gland atrophy and abnormal function may contribute to hair loss in psoriasis.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Dr. Jorizzo questions the long-term benefits of minoxidil and tretinoin, while Dr. Olsen defends their effectiveness and stresses the need for public education on these treatments.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Long-term etretinate use may cause delayed wound healing and extra tissue growth after injury.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.